Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Larkin, J; Chiarion-Sileni, V; Gonzalez, R; Grob, JJ; Rutkowski, P; Lao, CD; Cowey, CL; Schadendorf, D; Wagstaff, J; Dummer, R; Ferrucci, PF; Smylie, M; Hogg, D; Hill, A; Marquez-Rodas, I; Haanen, J; Guidoboni, M; Maio, M; Schoffski, P; Carlino, MS; Lebbe, C; McArthur, G; Ascierto, PA; Daniels, GA; Long, GV; Bastholt, L; Rizzo, JI; Balogh, A; Moshyk, A; Hodi, FS; Wolchok, JD.

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

NEW ENGLAND JOURNAL OF MEDICINE. 2019; 381(16): 1535-1546 Nº de citas: 2850 [doi:10.1056/NEJMoa1910836]

Garcia-Carbonero, R; Marquez-Rodas, I; de la Cruz-Merino, L; Martinez-Trufero, J; Cabrera, MA; Piulats, JM; Capdevila, J; Grande, E; Martin-Algarra, S; Berrocal, A.

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

ONCOLOGIST. 2019; 24(10): 1375-1383 Nº de citas: 21 [doi:10.1634/theoncologist.2018-0718]

Farge, D; Frere, C; Connors, JM; Ay, C; Khorana, AA; Muno, ZA; Brenner, B; Kakkar, A; Rafii, H; Solymoss, S; Brilhante, D; Monreal, M; Bounameaux, H; Pabinger, I; Douketis, J; Int Initiative Thrombosis Canc ITA.

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

LANCET ONCOLOGY. 2019; 20(10): 566-581 Nº de citas: 768 [doi:10.1016/S1470-2045(19)30336-5]

Agnelli, C; Valerio, M; Olmedo, M; Guinea, J; Zatarain-Nicolas, E; Del Carmen Martínez-Jiménez M; Alcala, L; Escribano, P; Cebollero Presmanes M; Bouza, E; Muñoz P; Martin-Rabadan, P.

Fatal disseminated infection by Gymnascella hyalinospora in a heart transplant recipient

TRANSPLANT INFECTIOUS DISEASE. 2019; 21(5): Nº de citas: 1 [doi:10.1111/tid.13128]

Cabezon-Gutierrez, L; Khosravi-Shahi, P; Palka-Kotlowska, M; Custodio-Cabello, S; Garcia-Martos, M.

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review of the Literature and a Single-center Experience

CUREUS JOURNAL OF MEDICAL SCIENCE. 2019; 11(9): Nº de citas: 8 [doi:10.7759/cureus.5640]

Khosravi-Shahi, P; Cabezon-Gutierrez, L; Salcedo, MIA.

State of art of advanced triple negative breast cancer

BREAST JOURNAL. 2019; 25(5): 967-970 Nº de citas: 26 [doi:10.1111/tbj.13369]

Isla, D; De Las Penas, R; Insa, A; Marse, R; Martinez-Banaclocha, N; Mut, P; Moran, T; Sala, MA; Massuti, B; Ortega, AL; Jurado, JM; Gomez-Codina, J; Diz, P; Artal, A; Gutierrez, V; Vazquez, MF; Vinolas, N; Maestu, I; Camps, C; Alvarez, R; Soto, MAD; Ponce, S; Provencio, M.

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)

LUNG CANCER. 2019; 135: 161-168 Nº de citas: 7 [doi:10.1016/j.lungcan.2018.11.041]

Nathan, P; Ascierto, PA; Haanen, J; Espinosa, E; Demidov, L; Garbe, C; Guida, M; Lorigan, P; Chiarion-Sileni, V; Gogas, H; Maio, M; Fierro, MT; Hoeller, C; Terheyden, P; Gutzmer, R; Guren, TK; Bafaloukos, D; Rutkowski, P; Plummer, R; Waterston, A; Kaatz, M; Mandala, M; Marquez-Rodas, I; Munoz-Couselo, E; Dummer, R; Grigoryeva, E; Young, TC; Schadendorf, D.

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

EUROPEAN JOURNAL OF CANCER. 2019; 119: 168-178 Nº de citas: 70 [doi:10.1016/j.ejca.2019.07.010]

Mulder, FI; Kraaijpoel, N; Di Nisio, M; Meyer, G; Mahe, I; Munoz, A; Bertoletti, L; Biosca, M; Maraveyas, A; Buller, HR; van Es, N.

The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism

THROMBOSIS RESEARCH. 2019; 181: 59-63 Nº de citas: 9 [doi:10.1016/j.thromres.2019.07.005]

Riechelmann, RP; Srimuninnimit, V; Bordonaro, R; Kavan, P; Di Bartolomeo, M; Maiello, E; Cicin, I; Garcia-Alfonso, P; Chau, I; Fedyanin, MY; Martos, CF; Ter-Ovanesov, M; Peeters, M; Ko, YJ; Yalcin, S; Karthaus, M; Aparicio, J; Heinemann, V; Picard, P; Bury, D; Drea, E; Sobrero, A.

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

CLINICAL COLORECTAL CANCER. 2019; 18(3): 183 Nº de citas: 16 [doi:10.1016/j.clcc.2019.05.003]

Mancha, RG; Munoz, M; de la Cruz-Merino, L; Calvo, L; Cruz, J; Baena-Canada, JM; Fernandez, Y; Ramos, M; Rodriguez, CA; Chacon, JI; Palomero, I; Llinares, J; Rivero, M; Ruiz, MA.

Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q"

HEALTH AND QUALITY OF LIFE OUTCOMES. 2019; 17(1): Nº de citas: 6 [doi:10.1186/s12955-019-1197-7]

Trigo, J; Vermorken, J; Bourhis, J; Psyrri, A; Nangia, CS; Chaves-Conde, M; Del Campo, JM; Wang, BS; Gibson, N; Ehrnrooth, E; Cohen, EEW; Giglio, RE; Blajman, CR; Freue, JM; Pilnik, NG; Palazzo, FS; McGrath, M; Fureder, T; Kornek, G; Pichler, A; Bauernhofer, T; Tinchon, C; Greil, R; Burian, M; Kienzer, H; Specenier, P; Sautois, B; Debruyne, P; Graas, MP; Maes, A; Lonchay, C; Daisne, JF; Fontaine, C; Castro, G; de Oliveira, F; Pereira, RP; De Marchi, PRM; Viana, LD; Segalla, JGM; Nicolau, UR; Lazaretti, NS; Kulkarni, S; Alam, Y; Ho, C; Shenouda, G; Soulieres, D; Sultanem, K; Singh, S; Mella, PG; Campos, JAS; Holeckova, P; Prausova, J; Obermannova, R; Friborg, J; Specht, L; Elsaid, AA; Minn, H; Martin, L; Rolland, F; Ceruse, P; Calais, G; Even, C; Guigay, J; Ferte, C; Peyrade, F; Duffaud, F; Champeaux-Orange, E; Coutte, A; Clatot, F; Fournel, P; Le Moal, LB; Dietz, A; Grunwald, V; Gauler, T; Guntinas-Lichius, O; Hildebrandt, G; Kuhnt, T; Schmidt, HJ; Henke, M; Ruckert, A; Brugger, W; Rotter, N; Mahlberg, R; Karavasilis, V; Fountzilas, G; Psyrri, D; Lang, I; Boer, A; Kocsis, J; Pajkos, G; Tamas, L; Anand, AL; Sharma, A; Sharma; Voona, M; Pandy, AS; Kumar, K; Nathan, RKP; Srinivasan, V; Zade, B; Jain, M; Srinivasa, BJ; Naik, R; Mohanty, BK; Asarawala, N; Charas, T; Billan, S; Popovtzer, A; Licitra, L; Ferrari, D; Fao, P; Merlano, M; Rocca, MC; Homma, A; Fujii, H; Tahara, M; Minami, S; Fujii, M; Yokota, T; Kadowaki, S; Muro, K; Kiyota, N; Okami, K; Yagi, T; Yoshino, K; Matsumoto, K; Takahashi, S; Matsuura, K; Avitia, MAA; Riestra, HJG; van Meerten, E; Buter, J; Gelderblom, AJ; Kawecki, A; Golusinski, W; Dinis, J; Dinis, R; Ribeiro, L; Silva, R; Mansinho, H; Selezneva, I; Biakhov, M; Galiulin, R; Izmailov, A; Romanov, I; Vladimirov, V; Vinogradov, V; Mufazalov, F; Vasilevskaya, I; Baste, N; del Campo, JM; Nin, RM; Pousa, AL; de Castro, JJG; Reig, O; Vera, R; Trigo, J; Iglesias, L; Trufero, JM; Vazquez, S; Rubio, B; Ales, JE; Villar, E; Rubio, J; Escobar, Y; Soria, A; Chaves, M; Johansson, GW; Friesland, S; Tell, R; Nyman, J; Rothschild, S; Zippelius, A; Rauch, D; Usluoglu, N; Gogunska, I; Zabolotniy, D; Vinnyk, Y; Burian, O; Harrington, K; Sykes, A; Peel, D; Lester, J; Robinson, M; Srinivasan, D; Fragkandrea-Nixon, I; Junor, E; Gollins, S; Evans, M; Newbold, K; Hwang, D; Schipani, S; Rizwanullah, M; Atiq, O; Arnaoutakis, K; Bauman, J; Burtness, B; Mehra, R; Kang, H; Chung, C; Davis, T; Haddad, R; Jimeno, A; Keresztes, R; Nangia, C; Ignatius, SH; Su, YB; Overton, LC; Garrison, MA; Jeong, W; Wehbe, A; Argiris, A; Chiang, A; Morgensztern, D; Haigentz, M; Martincic, D; Porosnicu, M; LUX-HEAD & Neck 2 Investigators.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

JAMA Oncology. 2019; 5(8): 1170-1180 Nº de citas: 20 [doi:10.1001/jamaoncol.2019.1146]

Martin, M; Loibl, S; Hyslop, T; De la Haba-Rodriguez, J; Aktas, B; Cirrincione, CT; Mehta, K; Barry, WT; Morales, S; Carey, LA; Garcia-Saenz, JA; Partridge, A; Martinez-Janez, N; Hahn, O; Winer, E; Guerrero-Zotano, A; Hudis, C; Casas, M; Rodriguez-Martin, C; Furlanetto, J; Carrasco, E; Dickler, MN; GEICAM Spanish Breast Canc Grp; GBG; Alliance Clinical Trials Oncolog.

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

EUROPEAN JOURNAL OF CANCER. 2019; 117: 91-98 Nº de citas: 16 [doi:10.1016/j.ejca.2019.06.002]

Ruiz-Borrego, M; Guerrero-Zotano, A; Bermejo, B; Ramos, M; Cruz, J; Baena-Canada, JM; Cirauqui, B; Rodriguez-Lescure, A; Alba, E; Martinez-Janez, N; Munoz, M; Antolin, S; Alvarez, I; Del Barco, S; Sevillano, E; Chacon, JI; Anton, A; Escudero, MJ; Ruiz, V; Carrasco, E; Martin, M; Segui, MA; Ayala, F; de la Haba, J; Martinez, P; Gonzalez, S; Lahuerta, A; Toral, JC; de Duenas, EM; Florian, J; Godes, MJ; Llorca, C; Blancas, I; Jara, C; Morales, S; Arcusa, A; Martinez, A; Vicente, E; de Juan, A; Rodriguez, M; Garcia, M; Garcia, P; Bayo, JL; Caranana, V; Casinello, J; Jolis, L; Gil, M; Canabate, C; Oltra, A; Ramirez, J; Lomas, M; Barnadas, A; Sureda, M; Carabantes, F; Moreno, I; Moreno, AL; GEICAM.

Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study

BREAST CANCER RESEARCH AND TREATMENT. 2019; 177(1): 115-125 Nº de citas: 17 [doi:10.1007/s10549-019-05296-8]

Peters, S; Clezardin, P; Marquez-Rodas, I; Niepel, D; Gedyes, C.

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

CLINICAL & TRANSLATIONAL ONCOLOGY. 2019; 21(8): 977-991 Nº de citas: 25 [doi:10.1007/s12094-018-02023-5]

Calles, A; Aguado, G; Sandoval, C; Alvarez, R.

The role of immunotherapy in small cell lung cancer

CLINICAL & TRANSLATIONAL ONCOLOGY. 2019; 21(8): 961-976 Nº de citas: 93 [doi:10.1007/s12094-018-02011-9]

Kraaijpoel N; Bleker SM; Meyer G; Mahé I; Muñoz A; Bertoletti L; Bartels-Rutten A; Beyer-Westendorf J; Porreca E; Boulon C; van Es N; Iosub DI; Couturaud F; Biosca M; Lerede T; Lacroix P; Maraveyas A; Aggarwal A; Girard P; Büller HR; Di Nisio M; UPE investigators.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

JOURNAL OF CLINICAL ONCOLOGY. 2019; 37(20): 1713-1720 Nº de citas: 97 [doi:10.1200/JCO.18.01977]

Ciruelos E; Alba E; López R; Lluch A; Martín M; Arroyo I; Navarro B; Carcedo D; Colomer R; Albanell J.

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval.

Oncotarget. 2019; 10(42): 4321-4332 [doi:10.18632/oncotarget.27039]